Frazier Financial Advisors, LLC Harrow Health, Inc. Transaction History
Frazier Financial Advisors, LLC
- $122 Billion
- Q1 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 12 shares of HROW stock, worth $300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 12
-0.0%
Holding current value
$300
Previous $135,000
17.78%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
126Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$98.1 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$75.3 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$54.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$45.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$23.8 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $677M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...